Regeneron

Regeneron

Regeneron

Official Twitter channel for Regeneron. We turn science into medicine for people with serious diseases. View our terms of engagement here our site
Type
B2c
Founded
1988
Raised
$8.9M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$8,900,000
Post-IPO equity - 2016
Health and Human Services
Team Size
1000+
Employees
Xconomy

Regeneron Pays Intellia $100M to Add Hemophilia to CRISPR R&D Pact

SiliconRepublic

Regeneron announces 60 new jobs for Limerick

Bloomberg Technology

Sanofi to Sell Regeneron Stake Worth About $13 Billion

Reuters Top News

Data on arthritis drug to treat coronavirus could come within weeks: Regeneron executive

CNBC Tech

Regeneron aims to have coronavirus antibody treatment ready for human testing by early summer

Reuters Top News

U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug...

Reuters Top News

U.S. judge rules for Regeneron, Sanofi in Amgen cholesterol drug...

Xconomy

Matching Amgen, Regeneron to Cut List Price of Heart Drug by 60%

Forbes , ENDPOINTS NEWS

Regeneron And Bluebird Team To Invent New Cell Therapies For Cancer

Science Health
Xconomy

Express Scripts Picks Regeneron Over Amgen, Cuts Heart Drug Price

Health Costs
Bloomberg

Sanofi and Regeneron's Price Gamble Is Worth It

Health
Xconomy

Regeneron to Slash Price of Cholesterol Drug After Showing It Saved Lives

Health
Bloomberg

Regeneron's Eylea Protection Is Weakening

Health Earnings
Xconomy

As AMD Race Tightens, Regeneron's Second Eye Drug Combo Falls Short

Health Earnings
Xconomy

Regeneron Touts Success in Big Asthma Drug Study, Plans FDA Filing

Robotics Health Earnings
Xconomy

FDA OKs Eczema Injection; Owners Regeneron, Sanofi Set $37K Price

Health
Xconomy

Regeneron: It’s Still Wait Until 2017 For Big Heart Drug Study

Health
Xconomy

Weeks After Deal, FDA Slaps Clinical Hold on Regeneron/Teva Pain Drug

Health
Xconomy

Ocular Therapeutix Inks Licensing Deal With Regeneron For Wet AMD

Health
Xconomy

Regeneron, in Pain Drug Race With Pfizer & Lilly, Gets $250M From Teva

Health